STOKE THERAPEUTICS INC's ticker is and the CUSIP is 86150R907. A total of 2 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,728 | -85.7% | 1,200 | -61.3% | 0.00% | – |
Q2 2023 | $32,953 | +97.8% | 3,100 | +55.0% | 0.00% | – |
Q1 2023 | $16,660 | -60.8% | 2,000 | -56.5% | 0.00% | – |
Q4 2022 | $42,458 | -86.2% | 4,600 | +91.7% | 0.00% | -100.0% |
Q3 2022 | $308,000 | +34.5% | 2,400 | -59.3% | 0.00% | – |
Q1 2021 | $229,000 | +2.7% | 5,900 | +63.9% | 0.00% | – |
Q4 2020 | $223,000 | +1615.4% | 3,600 | +800.0% | 0.00% | – |
Q3 2020 | $13,000 | -23.5% | 400 | -42.9% | 0.00% | – |
Q2 2020 | $17,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 400 | $13,000 | 0.00% |
SIMPLEX TRADING, LLC | 19 | $63,000 | 0.00% |